Jama hampton 02.02.2021 Trombosis Covid patogenia. Medscape Questions/Answers on Thrombotic Issues in SARS-CoV-2 Infection. Giuseppe Patti1, Veronica Lio1, Ilaria Cavallari2, Felice Gragnano3, Letizia Riva4, Paolo Calabrò3, Giuseppe Di Pasquale4, Vittorio Pengo5,6 and Andrea Rubboli7 on behalf of the Italian Study Group on Atherosclerosis, Thrombosis, Vascular Biology 1Department of Translational Medicine, "Maggiore della Carità" Hospital, University of Eastern Piedmont, Via Solaroli, 17, 28 100 Novara, Italy giuseppe.patti@uniupo.it 2Campus Bio-Medico University of Rome, Rome, Italy 3"Sant'Anna and San Sebastiano" Hospital of Caserta, University of Campania "Luigi Vanvitelli", Naples, Italy 4"Maggiore" Hospital, Bologna, Italy 5Campus Biomedico "Pietro d'Abano", University of Padua, Padua, Italy 6Fondazione Arianna" On Anticoagulation, Bologna, Italy 7"S.
Maria delle Croci" Hospital, Ravenna, Italy Disclosures GP: Lecture fee/consultant/advisory board for Amgen, Sanofi, Bayer, Boehringer Ingelheim, BMS-Pfizer, Daiichi Sankyo, Astra Zeneca, Sigma-Tau, Malesci, PIAM, and MSD. 30.11. Medscape Proactivos en prevención TEV. Thromb Haemos Frecuencia de tromboembolismo en COVID 10. Jama piazza 23.11 Dg y manejo tromboembolismo venoso por COVID. Am J Cardiovasc Drugs 2020 Hipercoagulabilidad or COVID. Medscpe 17.09 COVID y trombosis. MPR 20.08 Prevalence of Endotheliopathy in COVID 19–Associated Coagulopathy. 23.07 Blood Sangrado y trombosis por COVID. NEJM Journal Watch 13.08.covid 19 coagulopathy.
JAMA 20.07 Trombosis y COVID. MPR 29 Jun Clotting and COVID New Guidelines to Treat Coagulopathies COVID. Thrombosis in COVID-19: What We Know and How to Treat. CADTH Venous Thromboembolism Prophylaxis Covid-19. MPR 1 junio Trombosis y COVID. Medscape 19.05 Trombosis y biomarcadores. NEJM 21.05 Trombosis y COVID. Ann Intern Med 14.05 Tromboembolismo y mortalidad.
Ann Intern Med 15.05 Tromboembolismo en autopsias editorial. Ann Intern Med 14.05 autopsias Austria. Ann Intern Med 06.05 Autopsia y TVE. MPR 27.04 coagulopatía en severa COVID. Medscape14,04 Hipercoagulabilidad. 25.03 J Throm Haemostasia Guidance manejo coagulopatía COVID. NEJM Coagulopatía y síndrome antifosfolípido COVID 08. 06.05 NEJM carta parámetros coagulación y COVID. MPR 30.04 COVID y TVE.